Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

138 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Active, Not Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

NCT04711252

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Harbor City, California, United States
  • Research Site Solvang, California, United States
View all 263 locations
View Trial Details
Active, Not Recruiting

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

NCT05664243

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Louisville Hospital/James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details
Active, Not Recruiting

ASPIRIN Trial Belgium

NCT03464305

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
Locations
  • AZ Rivierenland campus Bornem (Sint Jozefkliniek) Bornem, Antwerpen, Belgium
  • AZ Klina Brasschaat, Antwerpen, Belgium
  • AZ Monica Deurne, Antwerpen, Belgium
  • UZ Antwerpen Edegem, Antwerpen, Belgium
View all 29 locations
View Trial Details

Related conditions